Daiwa Securities Group Inc. X Biotech Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$10.95 - $16.07 $700 - $1,028	-64 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$15.65 - $19.92 $1,565 - $1,992	-100 Reduced 60.98%	64 $1,000
Q3 2020 Nov 02, 2020	SELL	$13.97 - $21.16 $1,005 - $1,523	-72 Reduced 30.51%	164 $3,000
Q1 2020 May 14, 2020	BUY	$8.89 - $24.94 $35 - $99	4 Added 1.72%	236 $3,000
Q4 2019 Jan 31, 2020	BUY	$8.33 - $19.95 $1,932 - $4,628	232 New	232 $4,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.